Retatrutide - Alluvi Healthcare®
This pre-filled Retatrutide pen delivers 40mg of a triple agonist (GLP-1, GIP, and glucagon) for once-weekly research use.
- The description claims triple receptor activation with higher strength.
Specifications
- Retatrutide Pen
- 20mg, 40mg
Variants (2)
- 20mg — 270.00 USD — In stock
- 40mg — 340.00 USD — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
74%